Understanding how immune cells regulate inflammation through a specific receptor
Systemic coordination of pro-inflammatory immune reactions through dendritic cell-restricted sIL6R biogenesis
This study is looking at how special immune cells help control inflammation in the body by producing a helpful protein, and it aims to find new ways to improve treatments for conditions where inflammation is a problem.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts General Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10989907 on NIH RePORTER |
What this research studies
This research investigates how certain immune cells, known as conventional dendritic cells, produce a soluble form of the IL-6 receptor that helps manage inflammation in the body. By studying the mechanisms behind this process, the researchers aim to understand how to enhance immune responses and restore balance in inflammatory conditions. The approach involves examining the role of specific proteins that contribute to the release of this receptor, which could lead to new strategies for treating diseases characterized by excessive inflammation.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from inflammatory diseases or conditions characterized by dysregulated immune responses.
Not a fit: Patients with stable, non-inflammatory conditions or those not experiencing immune dysregulation may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for inflammatory diseases by restoring proper immune function.
How similar studies have performed: Previous research has shown promise in manipulating immune responses through similar mechanisms, indicating potential for success in this area.
Where this research is happening
Boston, United States
- Massachusetts General Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Lingwood, Daniel — Massachusetts General Hospital
- Study coordinator: Lingwood, Daniel
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.